PhD Martina Štampar

PhD Martina Štampar
no.: 39119 source: ARIS

researcher – active in research organisation
Edit
Research activity

Code Science Field Subfield
1.03.00  Natural sciences and mathematics  Biology   
1.08.00  Natural sciences and mathematics  Control and care of the environment   
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
393.99
A''
177.13
A'
249.74
A1/2
346.62
CI10
340
CImax
43
h10
12
A1
1.57
A3
0.08
Data for the last 5 years (citations for the last 10 years) on November 11, 2025; Data for score A3 calculation refer to period 2020-2024 (2023, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 20  363  294  14.7 
Scopus 19  414  336  17.68 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  National Institute of Biology  Department of Genetic Toxicology and Cancer Biology 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J7-60117  Degradation of Cyanotoxins Through Cold Plasma Technologies and Toxicological Characterisation of Transformation Products (CyanoCAPtox)   1/1/2025 - 12/31/2027  PhD Martina Štampar   2,005 
2. J2-50047  Plasma-assisted removal of emerging genotoxic contaminants from wastewater   10/1/2023 - 9/30/2026  PhD Martina Modic   2,793 
3. J1-4395  Development of novel multifunctional metal-oxide-based nanozymes and their toxicological characterisation (NaNoZymSafe)   10/1/2022 - 9/30/2025  PhD Bojana Žegura   2,961 
4. J1-4402  Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors   10/1/2022 - 9/30/2025  PhD Andrej Perdih   2,940 
5. BI-HR/23-24-006  Application of hepatic 3D cell model (HepG2) for safety evaluation of newly synthesized oximes, antidotes in treatment of organophosphate poisoning (OximeSafe3D)   4/1/2023 - 3/31/2025  PhD Martina Štampar   111 
6. J1-2471  Chemical Carcinogenesis: Mechanistic Insights   9/1/2020 - 8/31/2024  PhD Urban Bren   6,979 
7. Z1-3191  Bisphenol A and its analogues: Are BPA analogues hazardous for human health? (BPAnalogues)   10/1/2021 - 12/31/2023  PhD Martina Štampar   111 
8. J1-2465  Advanced 3D cell models: Bridging the gap between in vitro and in vivo experimental systems (hep3DGenTox)   9/1/2020 - 12/31/2023  PhD Bojana Žegura   3,464 
9. J1-9192  New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors   7/1/2018 - 6/30/2021  PhD Lucija Peterlin Mašič   2,479 
10. J1-8140  Endokrini in genotoksični potencial inhibitorjev proteinskih kinaz: pomen za tveganja za okolje in zdravje ljudi (Slovene)   5/1/2017 - 4/30/2020  PhD Metka Filipič   4,118 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   1/1/2019 - 12/31/2027 PhD Bojana Žegura   3,133 
2. P1-0245  Ecotoxicology, toxicogenomics and carcinogenesis   1/1/2015 - 12/31/2018 PhD Tamara Lah Turnšek   3,490 
We were not given permission by the researcher to publish data.
Confirmation required
Views history
Favourite